Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma

Emri, Salih; Dikmen, Gunnur; Ulasli, Sevinc Sarinc; Esendagli, Dorina; Yilmaz, Ugur; Şimşek Özek, Nihal; Severcan, Feride; OKUR, HAMZA; Akbiyik, Filiz

Makale Uluslararası 2017

Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma

Salih Emri, Gunnur Dikmen, Sevinc Sarinc Ulasli, Dorina Esendagli, Ugur Yilmaz, Nihal Şimşek Özek, Feride Severcan, HAMZA OKUR, Filiz Akbiyik

JOURNAL OF THORACIC ONCOLOGY Cilt 12 · Sayı 1 · 01.01.2017

Atıf için künye

Emri, S., Dikmen, G., Ulasli, S. S., Esendagli, D., Yilmaz, U., Şimşek Özek, N., Severcan, F., OKUR, H., & Akbiyik, F. (2017). Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma. JOURNAL OF THORACIC ONCOLOGY, 12(1).

BibTeX

@article{emri2017-54097,
  author = {Emri, Salih and Dikmen, Gunnur and Ulasli, Sevinc Sarinc and Esendagli, Dorina and Yilmaz, Ugur and Şimşek Özek, Nihal and Severcan, Feride and OKUR, HAMZA and Akbiyik, Filiz},
  title = {Diagnostic Utility of Mesothetin, Osteopontin and Megakaryocyte Potentiation Factor in Turkish Patients with Malignant Mesothelioma},
  journal = {JOURNAL OF THORACIC ONCOLOGY},
  year = {2017},
  volume = {12},
  number = {1},
  issn = {1556-0864},
  url = {https://akademik.atauni.edu.tr/yayinlar/54097-diagnostic-utility-of-mesothetin-osteopontin-and-megakaryocyte-potentiation}
}